Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $13,344 | $25,394 | $16,515 | $19,076 |
| % Growth | -47.5% | 53.8% | -13.4% | – |
| Cost of Goods Sold | $6,269 | $10,002 | $9,033 | $7,951 |
| Gross Profit | $7,075 | $15,392 | $7,481 | $11,125 |
| % Margin | 53% | 60.6% | 45.3% | 58.3% |
| R&D Expenses | $1,671 | $2,125 | $2,047 | $1,799 |
| G&A Expenses | $0 | $8,632 | $6,532 | $5,001 |
| SG&A Expenses | $6,535 | $8,879 | $8,010 | $6,555 |
| Sales & Mktg Exp. | $0 | $247 | $1,478 | $1,554 |
| Other Operating Expenses | $0 | $482 | $161 | $160 |
| Operating Expenses | $8,207 | $11,487 | $10,218 | $8,515 |
| Operating Income | -$1,132 | $3,905 | -$2,736 | $2,692 |
| % Margin | -8.5% | 15.4% | -16.6% | 14.1% |
| Other Income/Exp. Net | -$521 | -$234 | $2,697 | -$744 |
| Pre-Tax Income | -$1,653 | $3,671 | -$39 | $1,866 |
| Tax Expense | -$40 | $151 | $0 | $77 |
| Net Income | -$1,612 | $3,520 | -$39 | $1,789 |
| % Margin | -12.1% | 13.9% | -0.2% | 9.4% |
| EPS | -0.012 | 0.026 | -0 | 0.013 |
| % Growth | -145% | 8,700% | -102.3% | – |
| EPS Diluted | -0.012 | 0.026 | -0 | 0.013 |
| Weighted Avg Shares Out | 139,154 | 136,698 | 138,052 | 135,376 |
| Weighted Avg Shares Out Dil | 139,154 | 137,491 | 137,912 | 141,688 |
| Supplemental Information | – | – | – | – |
| Interest Income | $255 | $688 | $458 | $82 |
| Interest Expense | $682 | $922 | $839 | $827 |
| Depreciation & Amortization | $1,278 | $1,613 | $1,157 | $1,036 |
| EBITDA | $307 | $6,205 | $1,957 | $3,328 |
| % Margin | 2.3% | 24.4% | 11.9% | 17.4% |